These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3106125)
21. The mechanism of synergistic interaction between anti-interleukin 2 receptor monoclonal antibody and cyclosporine therapy in rat recipients of organ allografts. Ueda H; Hancock WW; Cheung YC; Diamantstein T; Tilney NL; Kupiec-Weglinski JW Transplantation; 1990 Oct; 50(4):545-50. PubMed ID: 2219270 [TBL] [Abstract][Full Text] [Related]
22. Cyclosporin A prolongation of segmental pancreatic and islet allograft function in rats. Rynasiewicz JJ; Sutherland DE; Kawahara K; Gorecki P; Najarian JS Transplant Proc; 1980 Jun; 12(2):270-4. PubMed ID: 6771903 [No Abstract] [Full Text] [Related]
23. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides. Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717 [TBL] [Abstract][Full Text] [Related]
24. Restoration of T cell responsiveness to interleukin-2 in recipients of pancreatic islet xenografts treated with cyclosporine. Nakajima Y; Kessler M; Nakano H; Lie TS Transplantation; 1985 Jul; 40(1):73-6. PubMed ID: 3925604 [TBL] [Abstract][Full Text] [Related]
25. Prolongation of rat pancreatic islet allograft survival by anti-CD2 monoclonal antibody treatment. Roark JH; Posselt AM; Campos L; Kim J; Chavin KD; Bromberg JS; Barker CF; Naji A Transplantation; 1992 Dec; 54(6):1098-9. PubMed ID: 1361253 [No Abstract] [Full Text] [Related]
26. Transplantation of purified islet cells in diabetic rats. III. Immunosuppressive effect of cyclosporin. Pipeleers-Marichal M; Ling ZD; Teng H; Pipeleers DG Diabetes; 1991 Jul; 40(7):931-8. PubMed ID: 2060729 [TBL] [Abstract][Full Text] [Related]
27. FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. Yasunami Y; Ryu S; Kamei T Transplantation; 1990 Apr; 49(4):682-6. PubMed ID: 1691535 [TBL] [Abstract][Full Text] [Related]
28. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation. Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031 [TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody treatment (anti-CD4 and anti-interleukin-2 receptor) combined with cyclosporin A has a positive but not simple dose-dependent effect on rat renal allograft survival. Steinbrüchel DA; Koch C; Kristensen T; Kemp E Scand J Immunol; 1991 Nov; 34(5):627-33. PubMed ID: 1947798 [TBL] [Abstract][Full Text] [Related]
30. Experience with islet immunoalteration in dogs: in vitro and in vivo studies. Kenyon NS; Alejandro R; Mintz DH Horm Metab Res Suppl; 1990; 25():119-22. PubMed ID: 2088950 [TBL] [Abstract][Full Text] [Related]
31. Development of suppressor lymphocytes during acute rejection of rat cardiac allografts and preservation of suppression by anti-IL-2-receptor monoclonal antibody. Schneider TM; Kupiec-Weglinski JW; Towpik E; Padberg W; Araneda D; Diamantstein T; Strom TB; Tilney NL Transplantation; 1986 Aug; 42(2):191-6. PubMed ID: 2943063 [TBL] [Abstract][Full Text] [Related]
32. Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and in human renal and pancreas transplantation. Rynasiewicz JJ; Sutherland DE; Ferguson RM; Squifflet JP; Morrow CE; Goetz FC; Najarian JS Diabetes; 1982 Aug; 31 Suppl 4():92-108. PubMed ID: 6819969 [TBL] [Abstract][Full Text] [Related]
33. Prolongation of graft survival in allogeneic islet transplantation by (-) 15-deoxyspergualin in the rat. Walter PK; Dickneite G; Schorlemmer HU; Sedlacek HH; Jäger S; Feifel G; Seitz G Diabetologia; 1987 Jan; 30(1):38-40. PubMed ID: 3106124 [TBL] [Abstract][Full Text] [Related]
34. The kinetics of tolerance induction by nondepleting anti-CD4 monoclonal antibody (RIB 5/2) plus intravenous donor alloantigen administration. Motoyama K; Arima T; Yu S; Lehmann M; Flye MW Transplantation; 2000 Jan; 69(2):285-93. PubMed ID: 10670640 [TBL] [Abstract][Full Text] [Related]
35. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492 [TBL] [Abstract][Full Text] [Related]
36. [The effect of individual MHC subregions (RT1.A,B,D) and treatment with anti-RT1.D monoclonal antibody on survival of pancreatic islet allograft in the rat]. Kim E Nihon Geka Gakkai Zasshi; 1989 May; 90(5):736-44. PubMed ID: 2507898 [TBL] [Abstract][Full Text] [Related]
37. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice. Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475 [TBL] [Abstract][Full Text] [Related]
38. Effects of ganglioside (Cronassial) treatment on MHC Ia antigen expression and allograft survival of pancreatic islets in diabetic rats. Bretzel RG; Flesch BK; Willig J; Woehrle M; Federlin K Diabetologia; 1990 Feb; 33(2):112-4. PubMed ID: 2109713 [TBL] [Abstract][Full Text] [Related]
39. Monotherapy with anti-LFA-1 monoclonal antibody promotes long-term survival of rat islet xenografts. Tredget EB; Arefanian H; Gill RG; Rajotte RV; Rayat GR Cell Transplant; 2008; 17(6):599-608. PubMed ID: 18819248 [TBL] [Abstract][Full Text] [Related]
40. Immunological studies in diabetic rat recipients with a pancreatic islet cell allograft in the brain. Tze WJ; Tai J Transplantation; 1989 Jun; 47(6):1053-7. PubMed ID: 2499961 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]